Department of Chemistry and Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, Georgia 30303, United States.
ACS Chem Biol. 2024 Mar 15;19(3):725-735. doi: 10.1021/acschembio.3c00750. Epub 2024 Feb 10.
With the recognition of the endogenous signaling roles and pharmacological functions of carbon monoxide (CO), there is an increasing need to understand CO's mechanism of actions. Along this line, chemical donors have been introduced as CO surrogates for ease of delivery, dosage control, and sometimes the ability to target. Among all of the donors, two ruthenium-carbonyl complexes, CORM-2 and -3, are arguably the most commonly used tools for about 20 years in studying the mechanism of actions of CO. Largely based on data using these two CORMs, there has been a widely accepted inference that the upregulation of heme oxygenase-1 (HO-1) expression is one of the key mechanisms for CO's actions. However, recent years have seen reports of very pronounced chemical reactivities and CO-independent activities of these CORMs. We are interested in examining this question by conducting comparative studies using CO gas, CORM-2/-3, and organic CO donors in RAW264.7, HeLa, and HepG2 cell cultures. CORM-2 and CORM-3 treatment showed significant dose-dependent induction of HO-1 compared to "controls," while incubation for 6 h with 250-500 ppm CO gas did not increase the HO-1 protein expression and mRNA transcription level. A further increase of the CO concentration to 5% did not lead to HO-1 expression either. Additionally, we demonstrate that CORM-2/-3 releases minimal amounts of CO under the experimental conditions. These results indicate that the HO-1 induction effects of CORM-2/-3 are not attributable to CO. We also assessed two organic CO prodrugs, BW-CO-103 and BW-CO-111. BW-CO-111 but not BW-CO-103 dose-dependently increased HO-1 levels in RAW264.7 and HeLa cells. We subsequently studied the mechanism of induction with an Nrf2-luciferase reporter assay, showing that the HO-1 induction activity is likely due to the activation of Nrf2 by the CO donors. Overall, CO alone is unable to induce HO-1 or activate Nrf2 under various conditions in vitro. As such, there is no evidence to support attributing the HO-1 induction effect of the CO donors such as CORM-2/-3 and BW-CO-111 in cell culture to CO. This comparative study demonstrates the critical need to consider possible CO-independent effects of a chemical CO donor before attributing the observed biological effects to CO. It is also important to note that such results cannot be directly extrapolated to studies because of the increased level of complexity and the likelihood of secondary and/or synergistic effects in the latter.
随着对一氧化碳(CO)内源性信号作用和药理学功能的认识,人们越来越需要了解 CO 的作用机制。沿着这条线,化学供体已被引入作为 CO 的替代物,以方便输送、剂量控制,有时还能靶向。在所有的供体中,两种钌羰基配合物,CORM-2 和 CORM-3,可以说是 20 年来研究 CO 作用机制最常用的工具。很大程度上基于使用这两种 CORM 的数据,人们普遍接受了这样一种推断,即血红素加氧酶-1(HO-1)表达的上调是 CO 作用的关键机制之一。然而,近年来有报道称,这些 CORM 具有非常明显的化学反应性和 CO 非依赖性活性。我们有兴趣通过在 RAW264.7、HeLa 和 HepG2 细胞培养物中使用 CO 气体、CORM-2/-3 和有机 CO 供体进行比较研究来检验这个问题。与“对照”相比,CORM-2 和 CORM-3 处理显示出显著的剂量依赖性诱导 HO-1,而孵育 6 小时 250-500 ppm CO 气体不会增加 HO-1 蛋白表达和 mRNA 转录水平。进一步将 CO 浓度增加到 5%也不会导致 HO-1 表达。此外,我们证明在实验条件下 CORM-2/-3 释放出的 CO 量很少。这些结果表明,CORM-2/-3 的 HO-1 诱导作用不能归因于 CO。我们还评估了两种有机 CO 前药,BW-CO-103 和 BW-CO-111。BW-CO-111 而非 BW-CO-103 剂量依赖性地增加了 RAW264.7 和 HeLa 细胞中的 HO-1 水平。随后,我们通过 Nrf2-荧光素酶报告基因测定研究了诱导机制,表明 HO-1 诱导活性可能是由于 CO 供体激活了 Nrf2。总的来说,在体外的各种条件下,CO 本身不能诱导 HO-1 或激活 Nrf2。因此,没有证据支持将 CORM-2/-3 和 BW-CO-111 等 CO 供体的 HO-1 诱导作用归因于 CO。这项比较研究表明,在将观察到的生物学效应归因于 CO 之前,有必要考虑化学 CO 供体可能存在的 CO 非依赖性效应。还需要注意的是,由于后者的复杂性增加以及可能存在的二次和/或协同效应,这些结果不能直接外推到研究中。